CTIS2023-509397-39-00进行中（未招募）1 期
An Adaptive, Open-Label, Dose-Finding, Phase 1/2 Study Investigating the Safety, Pharmacokinetics, and Clinical Activity of Rilzabrutinib (PRN1008), an Oral BTK Inhibitor, in Patients with Relapsed Immune Thrombocytopenia - DFI17124
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 83
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Male or female patients, aged 18 to 80 years old, Immune-related ITP (both primary and secondary)
排除标准
- •Pregnant or lactating women, Current drug or alcohol abuse, History of solid organ transplant, Positive screening for HIV, hepatitis B, or hepatitis C
研究者
相似试验
进行中（未招募）
1 期
A clinical trial to test the safety, dosing, effect and activity of PRN1008 in patients with Relapsed Immune ThrombocytopeniaImmune Thrombocytopenic Purpura (ITP)EUCTR2017-004012-19-BGPrincipia Biopharma, a Sanofi Company83
进行中（未招募）
1 期
A clinical trial to test the safety, dosing, effect and activity of PRN1008 in patients with Relapsed Immune ThrombocytopeniaImmune ThrombocytopeniaEUCTR2017-004012-19-CZPrincipia Biopharma, a Sanofi Company83
进行中（未招募）
1 期
A clinical trial to test the safety, dosing, effect and activity of PRN1008 in patients with Relapsed Immune ThrombocytopeniaMedDRA version: 23.0Level: LLTClassification code 10074667Term: Immune thrombocytopenic purpuraSystem Organ Class: 100000004851Immune ThrombocytopeniaEUCTR2017-004012-19-NLPrincipia Biopharma, a Sanofi Company83
进行中（未招募）
1 期
A clinical trial to test the safety, dosing, effect and activity of PRN1008 in patients with Relapsed Immune Thrombocytopenic PurpuraImmune Thrombocytopenic Purpura (ITP)MedDRA version: 23.0Level: LLTClassification code 10074667Term: Immune thrombocytopenic purpuraSystem Organ Class: 100000004851EUCTR2017-004012-19-NOPrincipia Biopharma Inc.40
招募中
2 期
An Adaptive, Open-Label, Dose-Finding, Phase 1/2 Study Investigating the Safety, Pharmacokinetics, and Clinical Activity of Rilzabrutinib (PRN1008), an Oral BTK Inhibitor, in Patients with Relapsed Immune ThrombocytopeniaImmune Thrombocytopenic Purpura (ITP)low platelets10035534NL-OMON52638Principia Biopharma, a Sanofi Company6